Australian-based medical technology company ImpediMed Limited has opened a regional office in Bloomington, MN., adding two local medical technology veterans to its executive team. The 55-person company develops products using bioimpedance spectroscopy (BIS) to measure, monitor and manage fluid status and body composition.
The Bloomington office, located at 2901 Metro Drive, will initially house employees in operations, marketing and business development roles, and is being positioned to become the hub for the company’s exploration of new clinical and home-based indications for its BIS technology. The company’s U.S. headquarters will remain in Carlsbad, CA. Its corporate headquarters is in Brisbane, Australia.
ImpediMed also announced the addition of Minnesota natives Ann Holder and Jack Cosentino, formerly with Medtronic, to its leadership team.
Holder serves as senior VP of general management and operations. She brings to the role her 13 years of experience at Medtronic, including serving as executive director of its integrated health services and solutions business. Before joining Medtronic, Holder served at PepsiCo, M&M/Mars, BoldTech Systems, General Mills and ADC Telecommunications. She is currently a board member for MobCon Digital Health, an annual conference focused on consumer medical devices.
Cosentino, now ImpediMed’s chief strategy officer, brings more than 20 years of experience as an advisor and leader at medical technology companies and organizations, including Medtronic, MentorMate, MobCon Digital Health and Diversified Medical Corp. Previously, he served as chief technology officer for the Medical Alley Association (formerly LifeScience Alley), the 700-member life sciences trade association based in Minneapolis.
Founded in 1999, ImpediMed develops and manufactures fluid measurement and body composition technology. Using BIS, the proprietary technology sends 256 unique frequencies through the body, providing a repeatable snapshot of a person’s lean body mass, fat mass, total body mass, intra- and extracellular fluid and water.
By detecting small amounts of fluid change within minutes, the technology can help health care providers detect and manage chronic disease in patients and gives individuals information to manage their health conditions or track wellness goals.
Potential clinical and at-home applications for the technology include oncology, cardiology, nephrology, veterinary and wellness.
